247 related articles for article (PubMed ID: 31953371)
1. Nonionotropic Action of Endothelial NMDA Receptors on Blood-Brain Barrier Permeability via Rho/ROCK-Mediated Phosphorylation of Myosin.
Mehra A; Guérit S; Macrez R; Gosselet F; Sevin E; Lebas H; Maubert E; De Vries HE; Bardou I; Vivien D; Docagne F
J Neurosci; 2020 Feb; 40(8):1778-1787. PubMed ID: 31953371
[TBL] [Abstract][Full Text] [Related]
2. NMDA mediates disruption of blood-brain barrier permeability via Rho/ROCK signaling pathway.
Yu Y; Wu Y; Wei J; Huang F; Mao F; Nong W; Cao X; Huang W
Neurochem Int; 2022 Mar; 154():105278. PubMed ID: 35017026
[TBL] [Abstract][Full Text] [Related]
3. Activation of non-classical NMDA receptors by glycine impairs barrier function of brain endothelial cells.
Epping L; Schroeter CB; Nelke C; Bock S; Gola L; Ritter N; Herrmann AM; Räuber S; Henes A; Wasser B; Fernandez-Orth J; Neuhaus W; Bittner S; Budde T; Platten M; Kovac S; Seebohm G; Ruck T; Cerina M; Meuth SG
Cell Mol Life Sci; 2022 Aug; 79(9):479. PubMed ID: 35951110
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.
Niego B; Lee N; Larsson P; De Silva TM; Au AE; McCutcheon F; Medcalf RL
PLoS One; 2017; 12(5):e0177332. PubMed ID: 28510599
[TBL] [Abstract][Full Text] [Related]
5. Methamphetamine reduces expressions of tight junction proteins, rearranges F-actin cytoskeleton and increases the blood brain barrier permeability via the RhoA/ROCK-dependent pathway.
Xue Y; He JT; Zhang KK; Chen LJ; Wang Q; Xie XL
Biochem Biophys Res Commun; 2019 Feb; 509(2):395-401. PubMed ID: 30594393
[TBL] [Abstract][Full Text] [Related]
6. The Emerging Role of N-Methyl-D-Aspartate (NMDA) Receptors in the Cardiovascular System: Physiological Implications, Pathological Consequences, and Therapeutic Perspectives.
Soda T; Brunetti V; Berra-Romani R; Moccia F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835323
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein(a), through its strong lysine-binding site in KIV(10'), mediates increased endothelial cell contraction and permeability via a Rho/Rho kinase/MYPT1-dependent pathway.
Cho T; Jung Y; Koschinsky ML
J Biol Chem; 2008 Nov; 283(45):30503-12. PubMed ID: 18776185
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid receptor, LPA
Masago K; Kihara Y; Yanagida K; Hamano F; Nakagawa S; Niwa M; Shimizu T
Biochem Biophys Res Commun; 2018 Jul; 501(4):1048-1054. PubMed ID: 29778535
[TBL] [Abstract][Full Text] [Related]
9. Adropin reduces paracellular permeability of rat brain endothelial cells exposed to ischemia-like conditions.
Yang C; DeMars KM; Hawkins KE; Candelario-Jalil E
Peptides; 2016 Jul; 81():29-37. PubMed ID: 27020249
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability.
Wu L; Ramirez SH; Andrews AM; Leung W; Itoh K; Wu J; Arai K; Lo EH; Lok J
J Neurochem; 2016 Jan; 136(2):250-7. PubMed ID: 26438054
[TBL] [Abstract][Full Text] [Related]
11. Roles of NMDARs in maintenance of the mouse cerebrovascular endothelial cell-constructed tight junction barrier.
Chen JT; Chen TG; Chang YC; Chen CY; Chen RM
Toxicology; 2016 Jan; 339():40-50. PubMed ID: 26655082
[TBL] [Abstract][Full Text] [Related]
12. t-PA-specific modulation of a human blood-brain barrier model involves plasmin-mediated activation of the Rho kinase pathway in astrocytes.
Niego B; Freeman R; Puschmann TB; Turnley AM; Medcalf RL
Blood; 2012 May; 119(20):4752-61. PubMed ID: 22262761
[TBL] [Abstract][Full Text] [Related]
13. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability.
McKenzie JA; Ridley AJ
J Cell Physiol; 2007 Oct; 213(1):221-8. PubMed ID: 17476691
[TBL] [Abstract][Full Text] [Related]
14. Role of Rho kinase in lysophosphatidic acid-induced altering of blood-brain barrier permeability.
Yu Y; Qin J; Liu M; Ruan Q; Li Y; Zhang Z
Int J Mol Med; 2014 Mar; 33(3):661-9. PubMed ID: 24398620
[TBL] [Abstract][Full Text] [Related]
15. The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier.
Reijerkerk A; Kooij G; van der Pol SM; Leyen T; Lakeman K; van Het Hof B; Vivien D; de Vries HE
J Neurochem; 2010 Apr; 113(2):447-53. PubMed ID: 20085611
[TBL] [Abstract][Full Text] [Related]
16. Increased activity of Rho kinase contributes to hemoglobin-induced early disruption of the blood-brain barrier in vivo after the occurrence of intracerebral hemorrhage.
Fu Z; Chen Y; Qin F; Yang S; Deng X; Ding R; Feng L; Li W; Zhu J
Int J Clin Exp Pathol; 2014; 7(11):7844-53. PubMed ID: 25550824
[TBL] [Abstract][Full Text] [Related]
17. Effects of NMDA receptor modulators on a blood-brain barrier in vitro model.
Neuhaus W; Freidl M; Szkokan P; Berger M; Wirth M; Winkler J; Gabor F; Pifl C; Noe CR
Brain Res; 2011 Jun; 1394():49-61. PubMed ID: 21549356
[TBL] [Abstract][Full Text] [Related]
18. Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction.
Allen C; Srivastava K; Bayraktutan U
Stroke; 2010 Sep; 41(9):2056-63. PubMed ID: 20651275
[TBL] [Abstract][Full Text] [Related]
19. Tetramethylpyrazine Protects Against Oxygen-Glucose Deprivation-Induced Brain Microvascular Endothelial Cells Injury via Rho/Rho-kinase Signaling Pathway.
Yang G; Qian C; Wang N; Lin C; Wang Y; Wang G; Piao X
Cell Mol Neurobiol; 2017 May; 37(4):619-633. PubMed ID: 27380043
[TBL] [Abstract][Full Text] [Related]
20. Blood tissue Plasminogen Activator (tPA) of liver origin contributes to neurovascular coupling involving brain endothelial N-Methyl-D-Aspartate (NMDA) receptors.
Furon J; Yetim M; Pouettre E; Martinez de Lizarrondo S; Maubert E; Hommet Y; Lebouvier L; Zheng Z; Ali C; Vivien D
Fluids Barriers CNS; 2023 Feb; 20(1):11. PubMed ID: 36737775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
